This observational study examines the use of glucose and lipid testing in Medicaid patients receiving antipsychotic therapy.
This population epidemiology study of patients with schizophrenia uses Medicaid data to compare overall and cause-specific mortality rates for adults with schizophrenia vs the US general population between 2001 and 2007.
This population-based cohort study reports an independent association of depression and diabetes mellitus (DM) with the risk for dementia in a national population sample from medical registries. See also the Invited Commentary by Reynolds.
This prospective cohort and risk score development study determines that risk prediction models for cardiovascular disease using body mass index and lipid levels perform better in people with severe mental illness compared with models that include only established risk factors.
This study assesses cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders.
Takayanagi et al examine the lifetime prevalence estimates of mental and physical disorders during midlife to late life using both retrospective and cumulative evaluations. Compton and Lopez provide commentary in a related editorial.